Early investigation of a novel SI306 theranostic prodrug for glioblastoma treatment.
Vagaggini C, Petroni D, D'Agostino I, Poggialini F, Cavallini C, Cianciusi A, Salis A, D'Antona L, Francesconi V, Manetti F, Damonte G, Musumeci F, Menichetti L, Dreassi E, Carbone A, Schenone S.
Vagaggini C, et al.
Drug Dev Res. 2024 Feb;85(1):e22158. doi: 10.1002/ddr.22158.
Drug Dev Res. 2024.
PMID: 38349262